ArticleFrontiers in cellular and infection microbiology2017
Comparison of Diabetic and Non-diabetic Human Leukocytic Responses to Different Capsule Types of
Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 24 citations in OpenAlex.
- Pulmonary Abscess, Endophthalmitis, and Lumbar Spine Infection Attributable to InvasiveInfection and drug resistance · 2026Article
- Treatment of liver abscess caused by Klebsiella pneumoniae with multi-site infection: a case report.Journal of medical case reports · 2025Article
- Understanding carbapenem-resistant hypervirulenthLife · 2024Review
- The Rapid Emergence of HypervirulentTropical medicine and infectious disease · 2024Review
- Alterations of Gut Microbiota in Pyogenic Liver Abscess Patients with and without Type 2 Diabetes Mellitus.Infection and drug resistance · 2024Article
- Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections.Human cell · 2023Review
- HypervirulentInfection and drug resistance · 2023Review
- The Bacterial Compositions of Nasal Septal Abscess in Patients with or without Diabetes.Life (Basel, Switzerland) · 2022Article
- Demographics, Radiological Findings, and Clinical Outcomes ofPathogens (Basel, Switzerland) · 2022Review
- Clinical Characteristics of Diabetes Complicated by Bacterial Liver Abscess and Nondiabetes-Associated Liver Abscess.Disease markers · 2022Article
- The Pathogenic Bacteria of Deep Neck Infection in Patients with Type 1 Diabetes, Type 2 Diabetes, and Without Diabetes from Chang Gung Research Database.Microorganisms · 2021Article
- A Molecular Interaction Map ofFrontiers in microbiology · 2021Article
- The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients.Scientific reports · 2020Article
- Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulentVirulence · 2020Article
- Clinical and computed tomography features of extended-spectrum β-lactamase-producing Klebsiella pneumoniae liver abscess.BMC infectious diseases · 2020Article
- Protective Role of Kupffer Cells and Macrophages in Klebsiella pneumoniae-Induced Liver Abscess Disease.Infection and immunity · 2019Article
- Cyclic AMP-CRP Modulates the Cell Morphology ofFrontiers in microbiology · 2019Article
- Evaluating Different Virulence Traits ofFrontiers in cellular and infection microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The major risk factor for Klebsiella liver abscess (KLA) is type 2 diabetes mellitus (DM), but the immunological mechanisms involved in the increased susceptibility are poorly defined. We investigated the responses of neutrophils and peripheral blood mononuclear cells (PBMCs) to hypervirulent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.